New Drug Pricing Deal Announced by Trump Administration
Viewers of *World News Tonight* with David Muir were surprised this week as the anchor detailed a new agreement between the administration of former President Donald Trump and two major…
Eli Lilly and Novo Nordisk Set to Cut Obesity Drug Prices
Eli Lilly and Novo Nordisk are poised to announce agreements with the White House that could significantly reduce the cost of their obesity medications. Reports indicate that the companies will…
Trump Urges Drug Companies to Cut Prices, Advocates Market Solutions
President Donald Trump has taken a firm stance on prescription drug prices, sending letters to 17 pharmaceutical companies urging them to lower their prices to match the lowest rates offered…
Grocery Chains Launch Affordable Weight-Loss Medications
Weight-loss medications such as Ozempic and Wegovy are now available to non-insured customers at several major grocery chains, including Costco, Sam’s Club, and Hy-Vee. These retailers have begun offering the…
Novo Nordisk Faces Challenges as Eli Lilly Boosts AI Initiative
A series of developments are reshaping the landscape of the pharmaceutical industry, as major players grapple with challenges and opportunities. Novo Nordisk, a leader in diabetes care, continues to navigate…
Novo Nordisk Restructures Amid Lowered Profit Growth Forecasts
BREAKING: Novo Nordisk has just announced a significant restructuring plan aimed at revitalizing its long-term investment strategy in diabetes and obesity treatments. The pharmaceutical giant is adjusting its 2025 operating…
Novo Nordisk and GoodRx Cut Ozempic Prices for Cash Buyers
Novo Nordisk and GoodRx have joined forces to offer significant price reductions on their medications, Ozempic and Wegovy, for patients paying in cash. Starting this week, customers will be able…
FDA Approves Wegovy for Liver Disease, Boosting Novo Nordisk Shares
URGENT UPDATE: Novo Nordisk’s stock is surging following the FDA’s recent approval of Wegovy for treating a specific form of liver disease. This landmark decision, announced on October 10, 2023,…
Novo Nordisk Partners with Fangzhou to Combat Chronic Diseases
Novo Nordisk A/S has entered a collaborative agreement with Fangzhou Inc., a prominent provider of internet healthcare solutions, to enhance the management of chronic diseases, particularly diabetes and obesity. The…
Novo Nordisk Ends Wegovy Partnership with Hims & Hers
NEW YORK – Novo Nordisk has announced the termination of its collaboration with telehealth company Hims & Hers, citing concerns over the promotion of unapproved versions of its weight loss…